NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Sector Expert: Casey Lynch

Image: Casey Lynch

Casey Lynch is the CEO of Cortexyme Inc. Previously she was the founder and managing director of NeuroInsights where she worked with companies to develop and implement strategic business plans and helps investors identify and profit from opportunities in neurotechnology. She is co-author of the Neurotechnology Industry Report, a comprehensive market analysis and strategic investment report on the brain industry, and is the managing editor of Neurotech Insights, a neurotechnology investment newsletter. She is interim CEO of the private Alzheimer's therapeutic development company Cortexyme Inc. Lynch is also on the board of directors of the Neurotechnology Industry Organization, a trade association for commercial neuroscience, and the co-founder and president of the Neurotechnology Development Foundation, a nonprofit formed to support translational research.



Recent Interviews

Digging Below the Surface of Neurotechnology: Casey Lynch (9/5/13)

Neuroscience is about as complex as it gets. The central nervous system contains the brain and spinal cord, where hundreds of billions of neurons are located—and that doesn't include the peripheral nervous system. Casey Lynch, managing director of NeuroInsights, works to make sense of both the disease processes affecting the nervous system and potential therapies that could help patients and enrich investors. In this interview with The Life Sciences Report, Lynch brings some clarity to the complexity, and speaks frankly about the wild goose that some Alzheimer's disease investigators have been chasing.



Due to permission requirements, not all quotes are shown.